Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leukocyte receptor tyrosine kinase (LTK) is a member of the receptor tyrosine kinase family closely related to anaplastic lymphoma kinase (ALK). It is encoded by the *LTK* gene on human chromosome 15. Unlike many other RTKs that localize at the plasma membrane, mammalian LTK predominantly resides within the endoplasmic reticulum where it regulates protein secretion and ER-to-Golgi transport by phosphorylating Sec12. In addition to its role in cellular proteostasis, LTK is involved in neural development—particularly supporting survival and migration of neural crest cells—and has been implicated in various diseases including cancer and autoimmunity. Its ligands include FAM150A and FAM150B (also known as ALKAL1/2), which activate its signaling pathway. While structurally similar to ALK, mammalian LTK has a smaller extracellular domain due to evolutionary deletions. The biological functions of LTK span signal transduction pathways that control cell growth, differentiation, survival under stress conditions such as during embryonic development or immune responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukocyte receptor tyrosine kinase (LTK).